当前位置: 首页 >> 检索结果
共有 312 条符合本次的查询结果, 用时 1.8516633 秒

201. Systematic review of blood biomarkers in cystic fibrosis pulmonary exacerbations.

作者: Alborz Hakimi Shoki.;Nicole Mayer-Hamblett.;Pearce G Wilcox.;Don D Sin.;Bradley S Quon.
来源: Chest. 2013年144卷5期1659-1670页
Biomarkers reflective of disease activity in cystic fibrosis (CF) have the potential to improve patient care, particularly during CF pulmonary exacerbations (CFPEs). Although blood-based biomarkers have been studied in CFPE for nearly 3 decades, none have been integrated into routine clinical practice. To facilitate progress in this area, we performed a systematic review evaluating blood-based biomarkers during CFPE.

202. Short- vs long-duration antibiotic regimens for ventilator-associated pneumonia: a systematic review and meta-analysis.

作者: George Dimopoulos.;Garyphallia Poulakou.;Ioannis A Pneumatikos.;Apostolos Armaganidis.;Marin H Kollef.;Dimitrios K Matthaiou.
来源: Chest. 2013年144卷6期1759-1767页
We performed a systematic review and meta-analysis of short- vs long-duration antibiotic regimens for ventilator-associated pneumonia (VAP).

203. Physiotherapy in intensive care: an updated systematic review.

作者: Kathy Stiller.
来源: Chest. 2013年144卷3期825-847页
Although physiotherapy is frequently provided to patients in the ICU, its role has been questioned. The purpose of this systematic literature review, an update of one published in 2000, was to examine the evidence concerning the effectiveness of physiotherapy for adult, intubated patients who are mechanically ventilated in the ICU.

204. Risk of serious atrial fibrillation and stroke with use of bisphosphonates: evidence from a meta-analysis.

作者: Abhishek Sharma.;Saurav Chatterjee.;Armin Arbab-Zadeh.;Sandeep Goyal.;Edgar Lichstein.;Joydeep Ghosh.;Shamik Aikat.
来源: Chest. 2013年144卷4期1311-1322页
Clinical studies have suggested an association between bisphosphonate use and the onset of atrial fibrillation (AF). However, data on the risk of developing AF, stroke, and cardiovascular mortality with the use of bisphosphonate are conflicting. The objective of this study was to evaluate the risk of serious AF (events that required hospital admission), stroke, and cardiovascular mortality with the use of bisphosphonates through a systematic review of the literature.

205. Cardiovascular comorbidity in COPD: systematic literature review.

作者: Hana Müllerova.;Alvar Agusti.;Sebhat Erqou.;Douglas W Mapel.
来源: Chest. 2013年144卷4期1163-1178页
Cardiovascular disease (CVD) is common among patients with COPD. However, it is not clear whether this is due to shared risk factors or if COPD increases the risk for CVD independently. This study aimed to provide a systematic review of studies that investigated the association between COPD and CVD outcomes, assessing any effect of confounding by common risk factors.

206. Respiratory muscle training for respiratory deficits in neurodegenerative disorders: a systematic review.

作者: Alvaro Reyes.;Mel Ziman.;Ken Nosaka.
来源: Chest. 2013年143卷5期1386-1394页
Studies of the impact of respiratory muscle training (RMT) on central neurodegenerative pathologies have been aimed at improving pulmonary function. However, there is no certainty about the effectiveness of RMT in patients affected by these groups of disorders. The purpose of this review was to assess the evidence regarding the efficacy of inspiratory muscle training (IMT) and expiratory muscle training (EMT) on respiratory function in patients with neurodegenerative disorders of the CNS.

207. Measurement of activities of daily living in patients with COPD: a systematic review.

作者: Tania Janaudis-Ferreira.;Marla K Beauchamp.;Priscila Games Robles.;Roger S Goldstein.;Dina Brooks.
来源: Chest. 2014年145卷2期253-271页
The objectives of this systematic review were to synthesize the literature on measures of activities of daily living (ADLs) that have been used in individuals with COPD and to provide an overview of the psychometric properties of the identified measures and describe the relationship of the disease-specific instruments with other relevant outcome measures for individuals with COPD and health-care use.

208. Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

作者: Frank C Detterbeck.;Peter J Mazzone.;David P Naidich.;Peter B Bach.
来源: Chest. 2013年143卷5 Suppl期e78S-e92S页
Lung cancer is by far the major cause of cancer deaths largely because in the majority of patients it is at an advanced stage at the time it is discovered, when curative treatment is no longer feasible. This article examines the data regarding the ability of screening to decrease the number of lung cancer deaths.

209. Lung cancer in China: challenges and interventions.

作者: Jun She.;Ping Yang.;Qunying Hong.;Chunxue Bai.
来源: Chest. 2013年143卷4期1117-1126页
In 2008, lung cancer replaced liver cancer as the number one cause of death among people with malignant tumors in China. The registered lung cancer mortality rate increased by 464.84% in the past 3 decades, which imposes an enormous burden on patients, health-care professionals, and society. We performed a systematic review of the published data on lung cancer in China between 1990 and 2011 to analyze the incidence and mortality rates, economic burden, and risk factors of cancer and the effectiveness of interventions. Lung cancer incidence varies within China. People in eastern China, especially women, likely have a higher risk of developing lung cancer than those in western China. The crude mortality rates from lung cancer in 2008 were 47.51 per 100,000 men and 22.69 per 100,000 women. The crude mortality rate was highest in Shanghai (76.49 per 100,000 men and 35.82 per 100,000 women) and lowest in Tibet (25.14 per 100,000 men) and Ningxia (12.09 per 100,000 women). Smoking and environmental pollution are major risk factors for lung cancer in China. Continuous efforts should be concentrated on education of the general public regarding lung cancer to increase prevention and early detection. Specific interventions need to be implemented to reduce smoking rates and environmental risk factors. Standardized treatment protocols should be adapted in China.

210. Systematic review of supervised exercise programs after pulmonary rehabilitation in individuals with COPD.

作者: Marla K Beauchamp.;Rachael Evans.;Tania Janaudis-Ferreira.;Roger S Goldstein.;Dina Brooks.
来源: Chest. 2013年144卷4期1124-1133页
The success of pulmonary rehabilitation (PR) is established, but how to sustain benefits over the long term is less clear. The aim of this systematic review was to determine the effect of supervised exercise programs after primary PR on exercise capacity and health-related quality of life (HRQL) in individuals with COPD.

211. Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis.

作者: Evan Atlantis.;Paul Fahey.;Belinda Cochrane.;Sheree Smith.
来源: Chest. 2013年144卷3期766-777页
The longitudinal associations between depression or anxiety and COPD, and their comorbid effect on prognosis, have not been adequately addressed by previous reviews. We aimed to systematically assess these associations to inform guidelines and practice.

212. Simulation-based bronchoscopy training: systematic review and meta-analysis.

作者: Cassie C Kennedy.;Fabien Maldonado.;David A Cook.
来源: Chest. 2013年144卷1期183-192页
Simulation-based bronchoscopy training is increasingly used, but effectiveness remains uncertain. We sought to perform a comprehensive synthesis of published work on simulation-based bronchoscopy training.

213. Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease.

作者: Peter J Kahrilas.;Colin W Howden.;Nesta Hughes.;Michael Molloy-Bland.
来源: Chest. 2013年143卷3期605-612页
Epidemiologic and physiologic studies suggest an association between gastroesophageal reflux disease (GERD) and chronic cough. However, the benefit of antireflux therapy for chronic cough remains unclear, with most relevant trials reporting negative findings. This systematic review aimed to reevaluate the response of chronic cough to antireflux therapy in trials that allowed us to distinguish patients with or without objective evidence of GERD.

214. Lack of efficacy of probiotics in preventing ventilator-associated pneumonia probiotics for ventilator-associated pneumonia: a systematic review and meta-analysis of randomized controlled trials.

作者: Wan-Jie Gu.;Chun-Yin Wei.;Rui-Xing Yin.
来源: Chest. 2012年142卷4期859-868页
Ventilator-associated pneumonia (VAP) remains a common hazardous complication in patients who are mechanically ventilated and is associated with increased morbidity and mortality.We undertook a systematic review and meta-analysis of randomized controlled trials to evaluate the efficacy and safety of probiotics for the prevention of VAP.

215. The costs of critical care telemedicine programs: a systematic review and analysis.

作者: Gaurav Kumar.;Derik M Falk.;Robert S Bonello.;Jeremy M Kahn.;Eli Perencevich.;Peter Cram.
来源: Chest. 2013年143卷1期19-29页
Implementation of telemedicine programs in ICUs (tele-ICUs) may improve patient outcomes, but the costs of these programs are unknown. We performed a systematic literature review to summarize existing data on the costs of tele-ICUs and collected detailed data on the costs of implementing a tele-ICU in a network of Veterans Health Administration (VHA) hospitals.

216. Adaptive servoventilation for treatment of sleep-disordered breathing in heart failure: a systematic review and meta-analysis.

作者: Bhavneesh K Sharma.;Jessie P Bakker.;David G McSharry.;Akshay S Desai.;Shahrokh Javaheri.;Atul Malhotra.
来源: Chest. 2012年142卷5期1211-1221页
Adaptive servoventilation (ASV) has demonstrated efficacy in treating sleep-disordered breathing (SDB) in patients with heart failure (HF), but large randomized trials are lacking. We, therefore, sought to perform a systematic review and meta-analysis of existing data.

217. The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe.

作者: Gregory Y H Lip.;Carolyn M Brechin.;Deirdre A Lane.
来源: Chest. 2012年142卷6期1489-1498页
Although atrial fibrillation (AF) is accepted as the most common sustained cardiac arrhythmia, most published epidemiologic studies focus on predominantly white populations in North America or Europe, and information on AF in nonwhite populations is scarce. The objective of this study was to undertake a systematic review of the published literature on the epidemiology of AF in other regions.

218. Intrapleural fibrinolytic therapy for treatment of adult parapneumonic effusions and empyemas: a systematic review and meta-analysis.

作者: Surinder Janda.;John Swiston.
来源: Chest. 2012年142卷2期401-411页
The purpose of our study was to conduct a systematic review and meta-analysis of all randomized controlled trials to date comparing fibrinolytics with placebo to clarify their current role in the management of parapneumonic effusions and empyemas.

219. Comparison of indacaterol with tiotropium or twice-daily long-acting β -agonists for stable COPD: a systematic review.

作者: Gustavo J Rodrigo.;Hugo Neffen.
来源: Chest. 2012年142卷5期1104-1110页
Bronchodilators are central to the symptomatic management of patients with COPD.Previous data have shown that inhaled indacaterol improved numerous clinical outcomes over placebo.

220. Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

作者: Samantha MacLean.;Sohail Mulla.;Elie A Akl.;Milosz Jankowski.;Per Olav Vandvik.;Shanil Ebrahim.;Shelley McLeod.;Neera Bhatnagar.;Gordon H Guyatt.
来源: Chest. 2012年141卷2 Suppl期e1S-e23S页
Development of clinical practice guidelines involves making trade-offs between desirable and undesirable consequences of alternative management strategies. Although the relative value of health states to patients should provide the basis for these trade-offs, few guidelines have systematically summarized the relevant evidence. We conducted a systematic review relating to values and preferences of patients considering antithrombotic therapy.
共有 312 条符合本次的查询结果, 用时 1.8516633 秒